Depression Research Today is a free monthly online journal that collates and summarizes the latest research about Depression, including details on clinical depression, medication, symptoms, treatment, counselling, therapy.

Volume 3 (2006), Issue 3 (March)

1. Major depression in female urinary incontinence.
   Psychosomatics, 47(2): 147-51. [Abstract] [Full-text]
2. A validation study of two brief measures of depression in the cardiac population: the DMI-10 and DMI-18.
   Psychosomatics, 47(2): 129-35. [Abstract] [Full-text]
3. Hepatitis C treatment for people with severe mental illness.
   Psychosomatics, 47(2): 93-107. [Abstract] [Full-text]
4. Utilization of health services in relation to mental health problems in adolescents: a population based survey.
   BMC Public Health, 6: 34. [Abstract] [Full-text]
5. Opportunities for cost-effective prevention of late-life depression: an epidemiological approach.
   Arch Gen Psychiatry, 63(3): 290-6. [Abstract] [Full-text]
6. Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit.
   Arch Gen Psychiatry, 63(3): 283-8. [Abstract] [Full-text]
7. Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study.
   Arch Gen Psychiatry, 63(3): 273-9. [Abstract] [Full-text]
8. Daytime prazosin reduces psychological distress to trauma specific cues in civilian trauma posttraumatic stress disorder.
   Biol Psychiatry, 59(7): 577-81. [Abstract] [Full-text]
9. Stimulation of neurogenesis in the hippocampus of the adult rat by fluoxetine requires rhythmic change in corticosterone.
   Biol Psychiatry, 59(7): 619-24. [Abstract] [Full-text]
10. Cortisol, the cortisol-dehydroepiandrosterone ratio, and pro-inflammatory cytokines in patients with current major depressive disorder comorbid with borderline personality disorder.
    Biol Psychiatry, 59(7): 667-71. [Abstract] [Full-text]
11. Corticotropin-releasing hormone, arginine vasopressin, gastrin-releasing peptide, and neuromedin B alterations in stress-relevant brain regions of suicides and control subjects.
    Biol Psychiatry, 59(7): 594-602. [Abstract] [Full-text]
12. Physician alerts to increase antidepressant adherence: fax or fiction?
    Arch Intern Med, 166(5): 498-504. [Abstract] [Full-text]
13. Maintenance treatment of major depression in old age.
    N Engl J Med, 354(11): 1130-8. [Abstract] [Full-text]
14. Acculturation, social alienation, and depressed mood in midlife women from the former Soviet Union.
    Res Nurs Health, 29(2): 134-46. [Abstract] [Full-text]
15. Predictors of distress in caregivers of persons with a primary malignant brain tumor.
    Res Nurs Health, 29(2): 105-20. [Abstract] [Full-text]
16. Predictive validity of the Depression Coping Self-Efficacy Scale (DCSES).
    Res Nurs Health, 29(2): 147-60. [Abstract] [Full-text]
17. Remissions in maternal depression and child psychopathology: a STAR*D-child report.
    JAMA, 295(12): 1389-98. [Abstract] [Full-text]
18. Medication augmentation after the failure of SSRIs for depression.
    N Engl J Med, 354(12): 1243-52. [Abstract] [Full-text]
19. Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.
    N Engl J Med, 354(12): 1231-42. [Abstract] [Full-text]
20. Quick assessment of hopelessness: a cross-sectional study.
    Health Qual Life Outcomes, 4: 13. [Abstract] [Full-text]
21. Expanded mental health benefits and outpatient depression treatment intensity.
    Med Care, 44(4): 366-72. [Abstract] [Full-text]
22. Modeling the impact of enhanced depression treatment on workplace functioning and costs: a cost-benefit approach.
    Med Care, 44(4): 352-8. [Abstract] [Full-text]
23. Methods for evaluating patient adherence to antidepressant therapy: a real-world comparison of adherence and economic outcomes.
    Med Care, 44(4): 300-3. [Abstract] [Full-text]

© 2004-2012 Depression Research Today. All Rights Reserved.